Invesco Biotechnology & Genome ETF
Invesco Biotechnology & Genome ETF reported 35 holdings worth US$282M as of Jul 31, 2026 (Form N-PORT)
As of Jul 31, 2026 · Filed Sep 28, 2026
Invesco Biotechnology & Genome ETF reported 35 holdings worth US$282M as of Jul 31, 2026. Largest: Regeneron Pharmaceuticals, Inc., Amgen Inc. and Caredx, Inc. Filed Sep 28, 2026 (Form N-PORT).
- Holdings
- 35
- Value as reported
- US$282M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Regeneron Pharmaceuticals, Inc. | 20,233 | US$15.4M | 5.5% |
| Amgen Inc. | 38,223 | US$14.7M | 5.2% |
| Caredx, Inc. | 325K | US$14.2M | 5.0% |
| Vertex Pharmaceuticals Incorporated | 29,460 | US$14.1M | 5.0% |
| Royalty Pharma Plc | 238K | US$13.9M | 4.9% |
| Biogen Inc. | 66,507 | US$13.5M | 4.8% |
| Gilead Sciences, Inc. | 96,026 | US$12.5M | 4.4% |
| United Therapeutics Corporation | 22,197 | US$11.5M | 4.1% |
| Bio-techne Corp | 146K | US$10.5M | 3.7% |
| Illumina, Inc. | 48,231 | US$9.89M | 3.5% |
| Protagonist Therapeutics, Inc. | 70,055 | US$9.57M | 3.4% |
| Vericel Corporation | 200K | US$9.21M | 3.3% |
| Alnylam Pharmaceuticals, Inc. | 43,457 | US$8.93M | 3.2% |
| Incyte Corporation | 72,136 | US$8.62M | 3.1% |
| Repligen Corporation | 60,807 | US$8.57M | 3.0% |
| Acadia Pharmaceuticals Inc. | 329K | US$8.52M | 3.0% |
| Halozyme Therapeutics, Inc. | 102K | US$8.41M | 3.0% |
| Qiagen N.v. | 197K | US$8.16M | 2.9% |
| Biomarin Pharmaceutical Inc. | 132K | US$7.95M | 2.8% |
| Neurocrine Biosciences, Inc. | 44,979 | US$7.5M | 2.7% |
| Exelixis, Inc. | 140K | US$7.43M | 2.6% |
| Biocryst Pharmaceuticals, Inc. | 827K | US$7.43M | 2.6% |
| Veracyte, Inc. | 158K | US$7.34M | 2.6% |
| Collegium Pharmaceutical, Inc. | 207K | US$7.34M | 2.6% |
| Omeros Corporation | 601K | US$7.12M | 2.5% |
| Ptc Therapeutics, Inc. | 104K | US$7.04M | 2.5% |
| Anaptysbio, Inc. | 121K | US$6.47M | 2.3% |
| Sarepta Therapeutics, Inc. | 420K | US$6.24M | 2.2% |
| Ardelyx, Inc. | 1.12M | US$5.55M | 2.0% |
| Mannkind Corporation | 0 | US$0 | 0.00% |
| Theravance Biopharma, Inc. | 0 | US$0 | 0.00% |
| Tg Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Catalyst Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Ionis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Arrowhead Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related